Health Care/Hospital

NYSE + Korea Exchange Agree to MOU for Business Collaboration: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 3, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-09-03 21:10 6264

Neurophet Appoints Leading U.S. Dementia Imaging Expert Dr. Ana M. Franceschi as Scientific Advisor

* Dr. Franceschi currently serves as Director of Dementia Imaging and Director of Molecular Neuroimaging at Northwell Health, where she has led advances in brain MRI and PET imaging technologies * Neurophet aims to strengthen the clinical evidence for its key products and accelerate its expan...

2026-09-03 21:00 2752

NUHS AND ITS INSTITUTIONS SECURE GOLD AND MULTIPLE AWARDS AT HOSPITAL MANAGEMENT ASIA AWARDS 2026

Six projects from across the healthcare cluster honoured for community impact, healthcare technology, sustainability and talent development SINGAPORE, Sept. 3, 2026 /PRNewswire/ -- To nurture a future-ready healthcare workforce, the National University Hospital (NUH) developed a scalable and sus...

2026-09-03 21:00 2812

Pulnovo Medical Announces Results of the PADN-HF-PH Trial at ESC Congress 2026, Simultaneously Published in The New England Journal of Medicine (NEJM)

Clinical outcomes from 264 PH-LHD patients demonstrate a 51% reduction in the risk of clinical worsening, a 35.5% decrease in recurrent clinical events, and sustained concurrent improvements in functional capacity, supporting the multi-dimensional therapeutic benefits of thePulmonary Artery Dener...

2026-09-03 19:53 1896

FutureCeuticals , Inc. (FC) and Aura Scientific Resolve Coffee Fruit Patent Dispute, Recognize FC Patent Rights, and Initiate Seamless Transition to CognatiQ®

MOMENCE, Ill., Sept. 3, 2026 /PRNewswire/ -- FutureCeuticals, Inc. (FC) and Aura Scientific (Aura) are pleased to announce the resolution of FutureCeuticals' patent and trademark suit related to Aura's NeuroRush® ingredient and FutureCeuticals' whole coffee fruit extract marketed under the trade...

2026-09-03 19:00 2015

Tucker Medical selects GE HealthCare MRI technology to advance personalized preventive care in Singapore

Collaboration will explore clinical education, knowledge exchange and imaging excellence across Southeast Asia * Tucker Medical has installed a SIGNA™ 1.5T magnetic resonance imaging system at its Novena Specialist Center in Singapore to support its personalized, risk-informed approach to asse...

2026-09-03 16:20 2531

ClinHope Officially Establishes Hong Kong Branch to Strengthen Asia-Pacific Market Presence

TAIPEI, Sept. 3, 2026 /PRNewswire/ -- ClinHope today announced the official establishment of its Hong Kong branch. Following its operations in Taiwan and the United States, this marks another step in expanding into the Asian market and deepening its global service footprint. As the biotech, phar...

2026-09-03 16:09 1700

In Indonesia, stroke care delays accumulate on the way to treatment, new report finds

Indonesian experts call for capability-based referral routing, greater investment in trained stroke teams and broader insurance coverage to close the gap between Western and Eastern Indonesia. JAKARTA, Indonesia, Sept. 3, 2026 /PRNewswire/ -- Structural delays occurring before patients reach tre...

2026-09-03 13:21 1830

Everest Medicines Announces China NMPA Approval of CARDAMYST® for the Conversion of Acute Symptomatic Episodes of Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm in Adults

SHANGHAI, Sept. 3, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that China's National Medical Product...

2026-09-03 13:20 2192

Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain

CAMBRIDGE, Mass., Sept. 2, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced that it will be included in the HKEX Tech 100 Index, following the methodology enhancements to broaden ...

2026-09-03 08:30 2306

The Galien Foundation Announces the Nominees for the Inaugural 2026 Prix Galien Korea Awards

Historic First Edition Launches in Partnership with MK Media (Maekyung), Yozma Group Korea, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), and KoreaBIO at the World Knowledge Forum in Seoul SEOUL, South Korea, Sept. 3, 2026 /PRNewswire/ -- The Galien Foundation, the p...

2026-09-03 08:00 1883

Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC

HONG KONG, Sept. 2, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that a pre-specified interim analysis of overall survival (OS) in the HARMONi-2 (AK112-303) trial, as assessed by the Independent Data Monitoring Committee (IDMC), met the key secondary endpo...

2026-09-03 05:00 2076

Helfie AI Appoints John Rego as Chief Financial Officer

Veteran CFO with more than $10 billion raised across six public and private companies joins Helfie AI to lead financial strategy MELBOURNE, Australia, Sept. 2, 2026 /PRNewswire/ -- Helfie AI ("Helfie"), an AI-powered preventative network transforming global healthcare by delivering personalised ...

2026-09-03 00:00 2096

EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction

PROVIDENCE, R.I., Sept. 3, 2026 /PRNewswire/ -- EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements toISPRI™ , its proprietary in sili...

2026-09-02 23:19 1720

Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 2, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-09-02 23:07 5357

Beyond the Smart Toothbrush: usmile Unveils Its First Visual Oral-Care System

NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Oral-care technology company usmile has introducedD Series, a new at-home visual preventive oral-care system led by its flagshipD50 OralCam Toothbrush and companion D-lite OralCam. Built around OralCam imaging, AI-assisted brushing guidance, plaque visualiz...

2026-09-02 22:00 1685

Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products

* Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 * Alteogen's fourth licensing agreement signed this year further accelerating the expansion of the Hybrozyme™ platform DAEJEON, South Korea, Sept. 2, 2026 /PRNewswire/ -- Al...

2026-09-02 19:00 2838

NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury

Round led by Neurimmune and Pureos, with participation from existing and new investors; complemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life - Spinal Cord Research Foundation. SCHLIEREN, Switzerland, Sept. 2, 2026 /PRNewswire/ -- NovaGo Therapeutics AG, a ...

2026-09-02 18:00 2482

Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC

WUXI, China, Sept. 2, 2026 /PRNewswire/ -- NORROY BIOSCIENCE (NORROY), a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that it has received regulatory clearance from China's National Medical Products Administration (NMPA) to initiate a pivotal...

2026-09-02 17:00 1692

BTL Establishes New Laser Division and Introduces EXOLASE ONE® - The World's First Fused Erbium Laser

Proprietary technology fuses multiple wavelengths into a single beam to set a new standard of care in laser facial rejuvenation. PRAGUE, Sept. 2, 2026 /PRNewswire/ -- BTL, a global leader in advanced energy-based medical and aesthetic technologies, today announced a major milestone in its corpor...

2026-09-02 16:00 1712
1234567 ... 849